Identification of 2,4-diarylaminopyrimidine analogues as ALK inhibitors by using 3D-QSAR, molecular docking, and molecular dynamics simulations

作者: Dan-Dan Li , Fu-Long Wu , Zhong-Hua Wang , Lei-Lei Huang , Yan Yin

DOI: 10.1007/S00706-017-1999-4

关键词: Anaplastic lymphoma kinaseLigand (biochemistry)Small moleculeComputational biologyField analysisChemistryBinding siteQuantitative structure–activity relationshipMolecular dynamics

摘要: Anaplastic lymphoma kinase (ALK) is a particularly promising target for the development of small molecule anti-cancer drugs. In present study, comparative molecular field analysis (CoMFA) and similarity indices (CoMSIA) were performed on 60 ALK inhibitors to build three-dimensional quantitative structure–activity relationship models. Both ligand-based resultants CoMFA (r 2 0.970, q 0.660) CoMSIA 0.979, 0.623) models exhibited good predictability. The resulting contour maps illustrated regions where interactive fields may affect activity. Molecular docking was then explore interactions between these ALK-4DCE protein. A few key residues (His32, Gly31, Gly169, Asp170, Val35, Ala100, Pro160, Lys50, Leu30) at binding site 4DCE identified. dynamics simulation further verified reliability. information acquired in this work not only provides better appreciation molecules receptor but could also be applied design more effective inhibitors.

参考文章(36)
J W Vardiman, M M Le Beau, M A Bitter, R A Larson, C M Rubin, E D Ellis, L A Doane, W A Franklin, M E Kadin, The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia. ,vol. 3, pp. 866- 870 ,(1989)
Hyoun Wook Lee, Kihyun Kim, Wonseog Kim, Young Hyeh Ko, ALK-positive diffuse large B-cell lymphoma: report of three cases. Hematological Oncology. ,vol. 26, pp. 108- 113 ,(2008) , 10.1002/HON.841
Zhipeng Ke, Tao Lu, Haichun Liu, Haoliang Yuan, Ting Ran, Yanmin Zhang, Sihui Yao, Xiao Xiong, Jinxing Xu, Anyang Xu, Yadong Chen, 3D-QSAR and molecular fragment replacement study on diaminopyrimidine and pyrrolotriazine ALK inhibitors Journal of Molecular Structure. ,vol. 1067, pp. 127- 137 ,(2014) , 10.1016/J.MOLSTRUC.2014.03.036
Jing Liu, Yan Li, Hui-Xiao Zhang, Shu-Wei Zhang, Ling Yang, Studies of H4R antagonists using 3D-QSAR, molecular docking and molecular dynamics Journal of Molecular Modeling. ,vol. 18, pp. 991- 1001 ,(2012) , 10.1007/S00894-011-1137-X
Li Ping Cheng, Xin Ying Huang, Zhi Wang, Zhen Peng Kai, Fan Hong Wu, Combined 3D-QSAR, molecular docking, and molecular dynamics study on potent cyclohexene-based influenza neuraminidase inhibitors Monatshefte Fur Chemie. ,vol. 145, pp. 1213- 1225 ,(2014) , 10.1007/S00706-014-1176-Y
Yaël P Mossé, Marci Laudenslager, Luca Longo, Kristina A Cole, Andrew Wood, Edward F Attiyeh, Michael J Laquaglia, Rachel Sennett, Jill E Lynch, Patrizia Perri, Geneviève Laureys, Frank Speleman, Cecilia Kim, Cuiping Hou, Hakon Hakonarson, Ali Torkamani, Nicholas J Schork, Garrett M Brodeur, Gian P Tonini, Eric Rappaport, Marcella Devoto, John M Maris, None, Identification of ALK as a major familial neuroblastoma predisposition gene Nature. ,vol. 455, pp. 930- 935 ,(2008) , 10.1038/NATURE07261
A. V. Galkin, J. S. Melnick, S. Kim, T. L. Hood, N. Li, L. Li, G. Xia, R. Steensma, G. Chopiuk, J. Jiang, Y. Wan, P. Ding, Y. Liu, F. Sun, P. G. Schultz, N. S. Gray, M. Warmuth, Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 270- 275 ,(2007) , 10.1073/PNAS.0609412103
Christine M. Lovly, Johannes M. Heuckmann, Elisa de Stanchina, Heidi Chen, Roman K. Thomas, Chris Liang, William Pao, Insights into ALK-Driven Cancers Revealed through Development of Novel ALK Tyrosine Kinase Inhibitors Cancer Research. ,vol. 71, pp. 4920- 4931 ,(2011) , 10.1158/0008-5472.CAN-10-3879